Showing results (371-380 of 582) with videos related to

Sort By:
Pageof 59
Journal of the Neurological Sciences|July 28, 2009
Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trialJoseph M Ferrara, Christopher Kenney, Anthony L Davidson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2006
A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremorFreddy Jeanneteau, Benoît Funalot, Joseph Jankovic, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 29, 2002
Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic stormPuneet Opal, Ron Tintner, Joseph Jankovic, et al.
Neuroscience Letters|June 1, 2005
Genetic analysis of parkin co-regulated gene (PACRG) in patients with early-onset parkinsonismHao Deng, Wei-Dong Le, Wen-Jie Xie, et al.
Toxicon : Official Journal of the International Society on Toxinology|November 27, 2012
Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disordersMarkus Naumann, Dirk Dressler, Mark Hallett, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|December 6, 2016
Deutetrabenazine in Tics Associated with Tourette SyndromeJoseph Jankovic, Joohi Jimenez-Shahed, Cathy Budman, et al.
Nature Reviews. Neurology|April 26, 2020
Parkinson disease and the immune system - associations, mechanisms and therapeuticsEng-King Tan, Yin-Xia Chao, Andrew West, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
The course of depressive symptoms in early Parkinson's diseaseBernard Ravina, Jordan Elm, Richard Camicioli, et al.
CNS & Neurological Disorders Drug Targets|April 10, 2012
Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's diseaseZhen Zhang, Xuping Li, Wen-jie Xie, et al.
Neurology|January 19, 2018
Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled studyWilliam G Ondo, Jerald H Simmons, Muhammad H Shahid, et al.
Pageof 59